Lilly China deeply empowers local pharmaceutical research and development capabilities to leap, incubating innovation at the source with a global perspective

Release time:Apr 16, 2024 05:38 AM

On August 31st, the "Gathering Ceremony, Creating Extraordinary - Lilly China Science Day" event was held at Zhangjiang Science City. On the spot, Lilly China officially announced that it had reached strategic cooperation with five local innovative biotechnology companies. This is another important manifestation of Lilly's commitment to continuously strengthening globalization and innovation in China, and achieving "rooted in China and benefiting China".

Lilly, which has successively established its China R&D center, regional headquarters, and China Innovation Cooperation Center in Pudong, is deeply empowering local pharmaceutical R&D capabilities through its own construction model, incubating innovation at the source with a global perspective, and further promoting the accelerated development of China's pharmaceutical industry.

Efficient combination of global experience and local innovation

Collaborative research and development accelerates China's innovative development

Biomedical industry is one of the three leading industries in Shanghai and also one of the six core industries that Pudong New Area focuses on developing. In the past 30 years, Pudong has developed into one of the regions with the most complete domestic biopharmaceutical industry chain, the best ecology, the most concentrated talents, the most active innovation, and the most fruitful achievements.

As a global leader in the healthcare industry, Eli Lilly is one of the first multinational pharmaceutical companies to carry out large-scale research and development activities in China, and also one of the earliest multinational pharmaceutical companies to establish partnerships with local Chinese enterprises in the field of new drug research and development.

Wu Qiang, Deputy District Mayor of Pudong New Area, attended the meeting and delivered a speech, stating that Lilly has successively laid out its China R&D center, regional headquarters, and China Innovation Cooperation Center in Pudong, playing a positive role in promoting the accelerated development of China's pharmaceutical industry, and also demonstrating the confidence of multinational pharmaceutical companies in Shanghai and their recognition of Pudong. "At present, Pudong is also actively promoting the development of the biopharmaceutical industry. We look forward to Lilly continuing to increase its layout in the Pudong New Area, supporting Pudong in building a 'science and technology innovation explosion point' with abundant innovation resources, a complete ecosystem, international influence, and a scale of billions of yuan. At the same time, we also hope to further promote scientific exchange and innovation cooperation through the 'Science Day' platform built by Lilly, and jointly build a comprehensive and open innovation ecosystem, contributing to the rapid development of China's pharmaceutical industry and the enhancement of international competitiveness."

In fact, over the past decade, Lilly China has established good research and development cooperation with multiple local enterprises by building independent research and development laboratories, promoting and managing collaborative research and development with external partners, and venture capital.

In 2018, Lilly China Innovation Cooperation Center was established in Zhangjiang, Pudong. Through its own mode of building the main body, Lilly is committed to effectively combining Lilly's global pharmaceutical experience with China's local innovative research and development, further promoting the accelerated development of China's pharmaceutical industry, effectively connecting China's current innovative ecological environment, better leveraging China's current favorable policy environment, faster promoting the development of new drugs, and bringing new breakthrough drugs to the world and Chinese patients.

At the meeting, it was revealed that after 5 years of development, the innovative products jointly developed by Lilly Innovation Cooperation Center and Chinese Biotechnology Company have had a huge impact on the lives of patients in China and globally. For example, the cooperation with Cinda Biology has laid the foundation for the research of PD-1 monoclonal antibody in China, and has cooperated with Junshi Biology to produce life saving neutralizing antibodies against COVID-19, which has become an important part of the combined therapy against COVID-19.

Dr. Ruth Gimeno, Vice President of Lilly diabetes, Obesity and Metabolic Diseases Research and Clinical Development Group, said: "The core team members of Lilly China Innovation Cooperation Center are all from Lilly Global Research and Development Center. They have many years of multinational pharmaceutical enterprises or overseas research background, and have rich experience in drug research and development and project management. As an important cooperation window of Lilly Global Research and Development in China, Lilly China Innovation Cooperation Center will continue to expand its pre clinical and early clinical research and development cooperation with China's outstanding biotechnology companies and academic institutions in various disease fields in the future, and is committed to achieving the common goal of 'China's innovation, serving the world'."


Lilly China deeply empowers local pharmaceutical research and development capabilities to leap, incubating innovation at the source with a global perspective

Zhangjiang Catalyst Incubation "From 0 to 1" Source Innovation

Multidimensional enabling local innovative pharmaceutical enterprise blueprint

In recent years, Lilly China Innovation Cooperation Center has been committed to innovative cooperation models and vigorously supports local biopharmaceutical startups. It has established strategic partnerships with over 20 local biopharmaceutical companies, including Xinda Biology, Junshi Biology, and Heyu Pharmaceutical.

In February 2022, the Zhangjiang catalytic converter was put into operation, and Eli Lilly continues to strengthen local pharmaceutical innovation cooperation. By adopting the method of self raised funds from Eli Lilly, we empower our partners and incubate "from 0 to 1" source innovation. Up to now, Lilly China Innovation Cooperation Center has provided technical and financial support and scientific consulting services for many Chinese local innovative enterprises, and provided exclusive research tools for cooperative enterprises by virtue of Lilly's rich global R&D experience, so as to achieve innovative cooperation modes such as technology empowerment, investment empowerment, and business empowerment, and help the development of local innovative drug enterprises in a multi-dimensional way.

"Eli Lilly has always been committed to supporting local biopharmaceutical innovation enterprises through internal research and development, cooperation with local pharmaceutical partners, and maximizing the efficient use of global resources to promote innovation project pipelines." Eli Lilly China President and General Manager Bei Liming said, "The implementation and promotion of various domestic policies have provided a favorable soil for the development of Chinese pharmaceutical innovation."

Text: Yang Zhenying, Qu Lichun

*Reprinted from official WeChat account released by Pudong

Two women were stabbed to death and reported to have committed a crime 4 days before the follow-up visit for schizophrenia. Suspect of a bloody murder case in a Hong Kong shopping mall appeared in court today. Male | Last Friday | Murder case
Two women were stabbed to death and reported to have committed a crime 4 days before the follow-up visit for schizophrenia. Suspect of a bloody murder case in a Hong Kong shopping mall appeared in court today. Male | Last Friday | Murder case

According to Hong Kong's Wen Wei Po, a bloody knife stabbing case occurred at Hollywood Square in Diamond Hill last Friday. The police arrested a 39 year old man on suspicion of stabbing two young women, one of whom was stabbed over 30 times. The suspect appeared in the Kwun Tong Magistrates Court this morning. The police at the Kwun Tong Magistrate's Court temporarily charged the suspect with two counts of murder last Sunday. The suspect appeared in court this morning at the Kwun Tong Magistrate's Court. Acting Chief Magistrate Zheng Jihang, after listening to the opinions of both the prosecution and defense, decided to postpone the hearing for two weeks until 9:30 am on June 19th, waiting for two psychiatric expert reports to be obtained. The defense did not object. Zheng Jihang approved the application, and the defendant needs to be temporarily detained at Xiaolan Mental Hospital. When the suspect appeared in court, he wore black framed glasses, a light gray shirt, and camouflage green shorts, and was able to answer the judge's questions normally. accordingly

Secretary of the Provincial Party Committee: The focus of Henan's "summer harvest" has shifted to agricultural machinery in the northern region of Henan Province. | Support | Science | Organization | Province | Northern Henan | Summer Harvest | Rush Harvest
Secretary of the Provincial Party Committee: The focus of Henan's "summer harvest" has shifted to agricultural machinery in the northern region of Henan Province. | Support | Science | Organization | Province | Northern Henan | Summer Harvest | Rush Harvest

Currently, the highly anticipated summer harvest work in Henan has shifted its focus to the northern region of Henan. According to the Henan Daily client, on June 4th, Lou Yangsheng, Secretary of the Henan Provincial Party Committee, presided over a special video scheduling meeting on the "Three Summers" work in the province, listened to the situation report, analyzed and judged the situation, and arranged and deployed the next steps of work. Governor Wang Kai made specific arrangements. On the evening of May 31, 2023, in Xiafutou Village, Xuliang Town, Boai County, Jiaozuo, Henan Province, villagers braved light rain in the wheat fields to harvest wheat. Visual China Map Lou Yangsheng pointed out that the current summer harvest battle in the province has entered the decisive stage. Doing a good job in summer harvest in northern Henan Province is related to the summer grain yield and seed safety. We should focus on seizing opportunities and make every effort to organize the wheat harvesting work in the northern Henan region, minimize losses, and protect the interests of farmers to the greatest extent possible. Accurate forecasting is essential

Xinhua All Media+| Welcome home! What innovative technologies are protecting the return journey of Shenzhou 15? Spaceship | Shenzhou | Technology
Xinhua All Media+| Welcome home! What innovative technologies are protecting the return journey of Shenzhou 15? Spaceship | Shenzhou | Technology

On June 4th, the return capsule of the Shenzhou-15 manned spacecraft successfully landed at the Dongfeng landing site. Astronauts Fei Junlong, Deng Qingming, and Zhang Lu all safely and smoothly exited the spacecraft, and the Shenzhou-15 manned flight mission was a complete success. What innovative technologies are there to safeguard the return journey of Shenzhou 15 in this mission? On June 4th, the return capsule of the Shenzhou-15 manned spacecraft successfully landed at the Dongfeng landing site. Xinhua News Agency reporter Lian Zhen photographed that "the sky and the ground" ensure the high-precision return of spacecraft. For the Shenzhou series spacecraft, the return and re-entry GNC technology is directly related to the life safety of astronauts. Taking the success of this return mission as a symbol, China has comprehensively upgraded its GNC system since the Shenzhou-12 manned spacecraft, which features autonomous rapid rendezvous and docking, autonomous adaptive prediction and re-entry return guidance, and has completed a comprehensive update and replacement

The Chinese naval fleet has arrived! Assembly | Navy | Chinese Fleet
The Chinese naval fleet has arrived! Assembly | Navy | Chinese Fleet

At noon today, a Chinese naval fleet consisting of Zhanjiang and Xuchang ships arrived at the assembly area of the "Comodo-2023" multinational maritime joint exercise. It is understood that the assembly anchorage for this exercise is 3 nautical miles long and 1.5 nautical miles wide, capable of anchoring up to 50 ships. Naval vessels from various countries participating in the exercise will also arrive at the anchorage today to complete the assembly of the "Komodo 2023" multinational maritime joint exercise, which is held every two years by the Indonesian Navy. This year is already the fourth edition of the exercise. The exercise will be held from June 5th to 8th in the city of Jakarta, South Sulawesi Province, Indonesia, including the port and sea phases. In the coming days, participating navies from various countries will participate in ship reading style search and rescue exercises, maritime interception and damage management exercises, aerial exercises, and other course objectives exercises

New comment: Donkey like "morale" limit pulls US debt "bomb" fuse hard to dismantle US | debt | morale
New comment: Donkey like "morale" limit pulls US debt "bomb" fuse hard to dismantle US | debt | morale

On the evening of June 1st, the US Senate passed a bill on the federal government's debt ceiling and budget, and the flame of the US debt bomb was temporarily extinguished at the last moment. The two parties in the United States have staged an extreme tug of war over the US debt bomb. Some experts believe that the US debt crisis is the result of the reckless politics promoted by the US dollar hegemony, and the underlying cause of this crisis is the highly polarized political system of the US. Since the end of World War II, the US Congress has adjusted the debt ceiling more than a hundred times. The recurring debt crisis will not only have a catastrophic impact on the US economy and people's livelihoods, but also continuously erode the value of US dollar assets such as government credit and US bonds, bringing significant and far-reaching impacts to the global economic landscape. 【